273 related articles for article (PubMed ID: 28920142)
1. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
[TBL] [Abstract][Full Text] [Related]
2. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Respond to author.
Zhang K; Gao C; Tang Q
Support Care Cancer; 2019 Sep; 27(9):3171-3172. PubMed ID: 30868268
[No Abstract] [Full Text] [Related]
3. Acupuncture improves certain aspects of sleep in hematopoietic stem cell transplantation patients: a secondary analysis of a randomized controlled trial.
El Iskandarani S; Sun L; Li SQ; Pereira G; Giralt S; Deng G
Acupunct Med; 2023 Dec; 41(6):319-326. PubMed ID: 37409464
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Li QS; Lapen K; Mao JJ
Pain Med; 2020 Mar; 21(3):636-642. PubMed ID: 31498394
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture As a Potential Opioid-Sparing Pain Management Intervention for Patients Undergoing Cancer Treatment.
Deng G
Med Acupunct; 2020 Dec; 32(6):394-395. PubMed ID: 33362896
[No Abstract] [Full Text] [Related]
6. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
Landau H; Wood K; Chung DJ; Koehne G; Lendvai N; Hassoun H; Lesokhin A; Hoover E; Zheng J; Devlin SM; Giralt S
Leuk Lymphoma; 2016 Aug; 57(8):1781-5. PubMed ID: 26758672
[TBL] [Abstract][Full Text] [Related]
7. Symptom burden after autologous stem cell transplantation for multiple myeloma.
Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
[TBL] [Abstract][Full Text] [Related]
8. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis.
Shah N; Shi Q; Williams LA; Mendoza TR; Wang XS; Reuben JM; Dougherty PM; Bashir Q; Qazilbash MH; Champlin RE; Cleeland CS; Giralt SA
Biol Blood Marrow Transplant; 2016 Feb; 22(2):226-231. PubMed ID: 26253006
[TBL] [Abstract][Full Text] [Related]
9. Pilot Trial of Homebound Hematopoietic Cell Transplantation.
Landau HJ; Orlando E; Rodriguez ES; Applebaum A; Mitchell HR; Peled JU; Khan N; Funnell T; Chung D; Scordo M; Shah GL; LeStrange NJ; Hambright KA; McElrath CM; Cazeau N; Devlin SM; Perales MA; Giralt SA
Transplant Cell Ther; 2022 Dec; 28(12):832.e1-832.e7. PubMed ID: 36182105
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Scordo M; Shah GL; Adintori PA; Knezevic A; Devlin SM; Buchan ML; Preston EV; Lin AP; Rodriguez NT; Carino CA; Nguyen LK; Sitner NC; Barasch A; Klang MG; Maloy MA; Mastrogiacomo B; Carlow DC; Schofield RC; Slingerland AE; Slingerland JB; Stein-Thoeringer CK; Lahoud OB; Landau HJ; Chung DJ; van den Brink MRM; Peled JU; Giralt SA
Cancer; 2022 Nov; 128(21):3850-3859. PubMed ID: 36041227
[TBL] [Abstract][Full Text] [Related]
11. Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.
Naegele M; Kirsch M; Ihorst G; Fierz K; Engelhardt M; De Geest S
Support Care Cancer; 2018 Mar; 26(3):833-841. PubMed ID: 28918604
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation.
Wang XS; Shi Q; Shah ND; Heijnen CJ; Cohen EN; Reuben JM; Orlowski RZ; Qazilbash MH; Johnson VE; Williams LA; Mendoza TR; Cleeland CS
Clin Cancer Res; 2014 Mar; 20(5):1366-74. PubMed ID: 24423611
[TBL] [Abstract][Full Text] [Related]
13. Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study.
Bates D; Bolwell B; Majhail NS; Rybicki L; Yurch M; Abounader D; Kohuth J; Jarancik S; Koniarczyk H; McLellan L; Dabney J; Lawrence C; Gallagher L; Kalaycio M; Sobecks R; Dean R; Hill B; Pohlman B; Hamilton BK; Gerds AT; Jagadeesh D; Liu HD
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1567-1572. PubMed ID: 28533058
[TBL] [Abstract][Full Text] [Related]
14. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
Shah N; Shi Q; Giralt S; Williams L; Bashir Q; Qazilbash M; Champlin RE; Cleeland CS; Wang XS
Qual Life Res; 2018 Apr; 27(4):979-985. PubMed ID: 29260444
[TBL] [Abstract][Full Text] [Related]
15. Strategies to improve the outcome of stem cell transplantation in multiple myeloma.
Catley L; Anderson K
Hematol J; 2004; 5(1):9-23. PubMed ID: 14745425
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
D'Souza A; Brazauskas R; Stadtmauer EA; Pasquini MC; Hari P; Bashey A; Callander N; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Landau H; Brunstein C; McCarthy P; Qazilbash MH; Giralt S; Krishnan A; Flynn KE
Am J Hematol; 2023 Jan; 98(1):140-147. PubMed ID: 35567778
[TBL] [Abstract][Full Text] [Related]
17. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
[TBL] [Abstract][Full Text] [Related]
18. Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
Schmitt T; Goldschmidt H; Neben K; Freiberger A; Hüsing J; Gronkowski M; Thalheimer M; Pelzl le H; Mikus G; Burhenne J; Ho AD; Egerer G
J Clin Oncol; 2014 Oct; 32(30):3413-20. PubMed ID: 25225424
[TBL] [Abstract][Full Text] [Related]
19. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
Malek E; Gupta V; Creger R; Caimi P; Vatsayan A; Covut F; Bashir Q; Champlin R; Delgado R; Rondon G; Cooper B; de Lima M; Lazarus HM; Qazilbash M
Leuk Lymphoma; 2018 Aug; 59(8):1905-1912. PubMed ID: 29295650
[TBL] [Abstract][Full Text] [Related]
20. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
